GSK kick-starts phase 3 Medicago-partnered COVID vaccine test

GSK kick-starts phase 3 Medicago-partnered COVID vaccine test

Source: 
Fierce Biotech
snippet: 

GlaxoSmithKline and Sanofi tripped up in a recent COVID-19 vaccine test, but the U.K. Big Pharma is hoping for better luck with its second partner Medicago.

The pair penned a vaccine deal last summer, wedding Canada-based Medicago’s recombinant coronavirus viruslike particles (CoVLPs) with GSK’s pandemic adjuvant system, which has been used in previous epidemics.